Oxford Drug Design Ltd. has announced additional in vivo validation for its novel approach against cancer. The innovative approach, using generative AI capabilities, is based on the novel target ...

A little-known mouse protein disrupts cancer-causing chemical changes to genes associated with human colorectal cancer cells and potentially could be used to treat solid tumors, according to a new ...

the research team developed and tested a drug strategy using those amino acids to treat colorectal cancer in cell lines and in a mouse model of cancer. Epigenetics refers to chemical alterations ...

Oxford Drug Design, the Oxford-based AI drug discovery company, has announced further in vivo validation for its ...

Fiber digestion produces short-chain fatty acids like propionate and butyrate, which directly alter gene expression with anti ...

Colorectal cancer (CRC) is stratified into ... Here the authors model the CRC subtypes with genetically engineered mouse organoids, identify the metabolic signature of CMS3 is driven by enterocyte ...

In a groundbreaking study, scientists at Korea Advanced Institute of Science and Technology (KAIST) have developed a ...